UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

An in vivo role for Rho kinase activation in the tumour vascular disrupting activity of combretastatin A‐4 3‐O‐phosphate

British journal of pharmacology, 2014-11, Vol.171 (21), p.4902-4913

2014

Volltextzugriff (PDF)

Vascular endothelial growth factor (VEGF) isoform mediated tumour response to combination treatment with a blocking antibody to VEGFR-2 and radiotherapy

European journal of cancer (1990), 2016-07, Vol.61, p.S146-S146

2016

Volltextzugriff (PDF)

19. Activation of the endoplasmic reticulum stress pathway and the radiosensitivity of human colorectal adenocarcinoma

European journal of surgical oncology, 2014-11, Vol.40 (11), p.S17-S17

2014

Volltextzugriff (PDF)

An automatic algorithm for the segmentation and morphological analysis of microvessels in immunostained histological tumour sections

Journal of microscopy (Oxford), 2011-06, Vol.242 (3), p.262-278

2011

Volltextzugriff (PDF)

Acute intraoperative heparin-induced thrombocytopenia (HIT) and thrombosis during coronary artery bypass grafting: Two case reports providing evidence for the role of preoperative LMWH in triggering sensitization

Thrombosis research, 2016-10, Vol.146, p.126-130

2016

Volltextzugriff (PDF)

Targeting the endoplasmic reticulum mediates radiation sensitivity in colorectal cancer

Experimental and molecular pathology, 2015-06, Vol.98 (3), p.532-539

2015

Volltextzugriff (PDF)

Tumour vascular disrupting agents: combating treatment resistance

British journal of radiology, 2008-10, Vol.81 Spec No 1 (special_issue_1), p.S12-S20

2008

Volltextzugriff (PDF)

Disrupting tumour blood vessels

Nature reviews. Cancer, 2005-06, Vol.5 (6), p.423-435

2005

Volltextzugriff (PDF)

The tumor vascular targeting agent combretastatin A–4-phosphate induces reorganization of the actin cytoskeleton and early membrane blebbing in human endothelial cells

Blood, 2002-03, Vol.99 (6), p.2060-2069

2002

Volltextzugriff (PDF)

Limitations of the reporter green fluorescent protein under simulated tumor conditions

Cancer research (Chicago, Ill.), 2001-06, Vol.61 (12), p.4784-4790

2001

Volltextzugriff (PDF)

Measuring cellular migration with image processing

Electronics letters, 2008, Vol.44 (13), p.791-793

2008

Volltextzugriff (PDF)

The Tubulin-Binding Agent Combretastatin A-4-Phosphate Arrests Endothelial Cells in Mitosis and Induces Mitotic Cell Death

The American journal of pathology, 2004-10, Vol.165 (4), p.1401-1411

2004

Volltextzugriff (PDF)

649 - Vascular endothelial growth factor (VEGF) isoform mediated tumour response to combination treatment with a blocking antibody to VEGFR-2 and radiotherapy

European journal of cancer (1990), 2016-07, Vol.61, p.S146-S146

2016

Volltextzugriff (PDF)

Use of low molecular weight heparin in pregnancy

Thrombosis and haemostasis, 1992-12, Vol.68 (6), p.652-656

1992

Volltextzugriff (PDF)

Expression of vascular endothelial growth factor receptors in smooth muscle cells

Journal of cellular physiology, 2001-09, Vol.188 (3), p.359-368

2001

Volltextzugriff (PDF)

The biology of the combretastatins as tumour vascular targeting agents

International journal of experimental pathology, 2002-02, Vol.83 (1), p.21-38

2002

Volltextzugriff (PDF)

An in vivo role for R ho kinase activation in the tumour vascular disrupting activity of combretastatin A ‐4 3‐ O ‐phosphate

British journal of pharmacology, 2014-11, Vol.171 (21), p.4902-4913

2014

Volltextzugriff (PDF)

The proliferative responsiveness of human vascular smooth muscle cells to endothelin correlates with endothelin receptor density

Laboratory investigation, 1995-03, Vol.72 (3), p.376

1995

Volltextzugriff (PDF)

Preclinical and Clinical Effects of RAS Inhibition with a Focus on Telmisartan

ISRN vascular medicine, 2012-08, Vol.2012 (2012), p.1-11

2012

Volltextzugriff (PDF)

O2 Protein S is expressed by cultured human vascular smooth muscle cells

Blood coagulation & fibrinolysis, 1998-11, Vol.9 (8), p.770

1998

Volltextzugriff (PDF)

The anticoagulant factor, protein S, is produced by cultured human vascular smooth muscle cells and its expression is up-regulated by thrombin

Blood, 2000-03, Vol.95 (6), p.2008-2014

2000

Volltextzugriff (PDF)

Thrombin receptor activating peptide (TRAP) stimulates mitogenesis, c-fos and PDGF-A gene expression in human vascular smooth muscle cells

Thrombosis and haemostasis, 1995-11, Vol.74 (5), p.1340-1347

1995

Volltextzugriff (PDF)

Measuring cellular migration with image processing

Electronics letters, 2008-06, Vol.44 (13), p.1-1

2008

Volltextzugriff (PDF)

Evidence for a protein S receptor(s) on human vascular smooth muscle cells. Analysis of the binding characteristics and mitogenic properties of protein S on human vascular smooth muscle cells

Biochemical journal, 1995-06, Vol.308 ( Pt 2) (2), p.481-485

1995

Volltextzugriff (PDF)

Mechanisms of cytotoxicity induced by horseradish peroxidase/indole-3-acetic acid gene therapy

Journal of cellular biochemistry, 2002, Vol.87 (2), p.221-232

2002

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(51)
Dissertationen
(2)

Sprache

Englisch
(53)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

An in vivo role for Rho kinase activation in the tumour vascular disrupting activity of combretastatin A‐4 3‐O‐phosphate

Vascular endothelial growth factor (VEGF) isoform mediated tumour response to combination treatment with a blocking antibody to VEGFR-2 and radiotherapy

19. Activation of the endoplasmic reticulum stress pathway and the radiosensitivity of human colorectal adenocarcinoma

An automatic algorithm for the segmentation and morphological analysis of microvessels in immunostained histological tumour sections

Acute intraoperative heparin-induced thrombocytopenia (HIT) and thrombosis during coronary artery bypass grafting: Two case reports providing evidence for the role of preoperative LMWH in triggering sensitization

Targeting the endoplasmic reticulum mediates radiation sensitivity in colorectal cancer

Tumour vascular disrupting agents: combating treatment resistance

Disrupting tumour blood vessels

The tumor vascular targeting agent combretastatin A–4-phosphate induces reorganization of the actin cytoskeleton and early membrane blebbing in human endothelial cells

Limitations of the reporter green fluorescent protein under simulated tumor conditions

Measuring cellular migration with image processing

The Tubulin-Binding Agent Combretastatin A-4-Phosphate Arrests Endothelial Cells in Mitosis and Induces Mitotic Cell Death

649 - Vascular endothelial growth factor (VEGF) isoform mediated tumour response to combination treatment with a blocking antibody to VEGFR-2 and radiotherapy

Use of low molecular weight heparin in pregnancy

Expression of vascular endothelial growth factor receptors in smooth muscle cells

The biology of the combretastatins as tumour vascular targeting agents

An in vivo role for R ho kinase activation in the tumour vascular disrupting activity of combretastatin A ‐4 3‐ O ‐phosphate

The proliferative responsiveness of human vascular smooth muscle cells to endothelin correlates with endothelin receptor density

Preclinical and Clinical Effects of RAS Inhibition with a Focus on Telmisartan

O2 Protein S is expressed by cultured human vascular smooth muscle cells

The anticoagulant factor, protein S, is produced by cultured human vascular smooth muscle cells and its expression is up-regulated by thrombin

Thrombin receptor activating peptide (TRAP) stimulates mitogenesis, c-fos and PDGF-A gene expression in human vascular smooth muscle cells

Measuring cellular migration with image processing

Evidence for a protein S receptor(s) on human vascular smooth muscle cells. Analysis of the binding characteristics and mitogenic properties of protein S on human vascular smooth muscle cells

Mechanisms of cytotoxicity induced by horseradish peroxidase/indole-3-acetic acid gene therapy

Suchergebnisse filtern